Amphastar Pharmaceuticals, Inc. has reported 26% growth in its fourth quarter sales to $120.9m, up from $95.9m reported in the prior-year period. For the full year of 2021, turnover was also up by a quarter at $437.8m.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?